Dr. Lizi Wu, an Assistant Professor in the Department of Molecular Genetics and Microbiology and a member of Shands Cancer Center, won a Technology Transfer Feasibility Grant from the Bankhead-Coley Cancer Research Program, part of the Florida Biomedical Research Programs. These grants help researchers develop early-stage technologies with potential for commercialization. The program has an open Call for Technology Transfer Feasibility (TTF) Grants now.
Florida public and private colleges and universities, and established research institutions operating within Florida are eligible. Besides the Bankhead-Coley Cancer Research Program, the James & Esther King Biomedical Research Program also has an open Call for Grant Applications. Technology Transfer Feasibility grants are awarded to the university/institution and do not require a company match. They fund a broad range of cancer-related projects, not limited to compound development.
Dr. Wu’s research focuses on stem cell maintenance, cell fate determination and oncogenic transformation. Her research group has a particular interest in studying molecular regulation of an oncogenic pathway, the Notch signaling pathway, and hopes that research insights will lead to novel therapeutic approaches for cancers with deregulated Notch signaling.
Dr. Wu served as a postdoctoral fellow at the Dana-Farber Cancer Institute at Harvard Medical School after earning her Ph.D. at Northeastern University in Boston. She earned a B.S. at Xiamen University in China.